Marc Schindewolf (M Schindewolf)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Peripheral Artery Disease

Antiplatelet Therapy

Top Venues

Vascular medicine (London, England)

Contact dermatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksandra Tuleja, Dante Salvador, Taulant Muka, Sarah M Bernhard, Armando Lenz, Iris Baumgartner, Marc Schindewolf
Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia. Blood advances 6 (10) (2022)
Tim Sebastian, Stefano Barco, Michael Lichtenberg, Stefan Stahlhoff, Oliver Schlager, Houman Jalaie, Rick de Graaf, Christian Erbel, Alexander Massmann, Marc Schindewolf, Nils Kucher
Twelve-month clinical outcomes of a hybrid oblique self-expanding nitinol stent used for the treatment of post-thrombotic syndrome with common iliac vein compression: The TOPOS study. Vascular medicine (London, England) 26 (5) (2021)
Jörn F Dopheide, Hana Ramadani, Luise Adam, Brigitta Gahl, Lucija Papac, Jonas Veit, Mathias Kaspar, Marc Schindewolf, Iris Baumgartner, Heinz Drexel
Development of a 3-Dimensional Prognostic Score for Patients With Symptomatic Peripheral Artery Disease: PAD3D Score. Angiology 71 (7) (2020)
Marc Schindewolf, Jan Beyer-Westendorf, Janita Balradj, Kevin Bowrin, Maria Huelsebeck, Jean-Baptiste Briere
Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery Disease. Angiology 71 (9) (2020)
Marc Schindewolf, M Paulik, H Kroll, R Kaufmann, M Wolter, W-H Boehncke, E Lindhoff-Last, A Recke, R J Ludwig
Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 48 (8) (2018)
Marc Schindewolf, Torsten Fuss, Hanspeter Fink, Armin Gemperli, Axel Haine, Iris Baumgartner
Efficacy Outcomes of Endovascular Versus Surgical Revascularization in Critical Limb Ischemia: Results From a Prospective Cohort Study. Angiology 69 (8) (2018)
Marc Schindewolf, Andreas Recke, Detlef Zillikens, Edelgard Lindhoff-Last, Ralf J Ludwig
Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responses. Contact dermatitis 77 (1) (2017)